Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 05 Apr 2023
Scientists have conducted a first-of-its-kind study in a collaboration between King Abdullah University of Science and Technology (KAUST), King Abdulaziz University, Jeddah (KAU), and King Abdulaziz University Hospital, Jeddah (KAUH).
Read Full NewsAD109 Yields Numerically Greater OSA Improvements in Postmenopausal Women
CHEST 2026: Day 3 Recap — 6 Headlines to Know
Downar outlines the randomized trial needed to confirm optimal TMS dosing and addresses a safety ceiling on total pulses.
The chief research and medical affairs officer at the National MS Society discussed AI-enabled imaging, biomarkers of progression, women's health across the lifespan, and the Society's Campaign to End MS.
One-year data from the phase 3 AQUARELLE study found that divozilimab, an anti-CD20 antibody, reduced relapse risk in patients with neuromyelitis optica spectrum disorder.
Early phase 1 data in 3 patients suggest CTA313, an allogeneic CD19/BCMA CAR-T, may stabilize disability with a manageable safety profile in progressive MS.
Fast Track status covers AV-1959R, an investigational amyloid-beta vaccine, for preventing Alzheimer disease in cognitively unimpaired adults with amyloid pathology.
1.
New BiTE Agent for Small Cell Lung Cancer Approved by the FDA.
2.
These Medical Doctors Are Real Comedians: Should Doctors Be Funnier?
3.
Novel radiotracer identifies biomarker for triple-negative breast cancer
4.
Should the UK introduce targeted prostate cancer screening? The case for and against
5.
Unlocking the potential of targeted therapies for multiple myeloma
1.
Decoding the Padua Score to Prevent Blood Clots in High-Risk Patients
2.
Cemiplimab: A Revolutionary Drug For Treating Cancer
3.
Cancer Diagnosis in 2025: Innovations, Education, and Evolving Clinical Strategies
4.
Unlocking The Causes And Risk Factors Of Breast Cancer
5.
Unlocking The Power Of Cangrelor To Treat Heart Disease
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Should We Use DARA Up Front As First-Line Therapy in MM?
2.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge